Myocarditis and cardiomyopathy: Underestimated complications resulting from clozapine therapy;Myocarditis en cardiomyopathie; Ernstige complicaties van clozapinetherapie

Tijdschrift voor Psychiatrie

Volumn 52, Issue 4, 2010, Pages 223-233

  Kamphuis, H ^a   Arends, J ^a   Timmerman, L ^a   Van Marle, J ^b   Kappert, J ^a  

^a GGZ Drenthe   (Netherlands)

^b GGZ Drenthe   (Netherlands)

Author keywords

Cardiomyopathy; Clozapine; Guideline; Monitoring; Myocarditis

Indexed keywords

CLOZAPINE;

ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; LABORATORY TEST; MEDLINE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT MONITORING; PRACTICE GUIDELINE;

ANTIPSYCHOTIC AGENTS; CARDIOMYOPATHIES; CLOZAPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; PREVALENCE; PSYCHOTIC DISORDERS;

EID: 77951265284     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Annamraju, S., Sheitman, B., & Saik, S. (2007). Early recognition of clozapine-induced myocarditis. Journal of Clinical Psychopharmacology, 27, 479-483. (Pubitemid 47415046)
2. Aretz, HT., Billingham, M.E., Edwards, W.D. e.a. (1987). Myocarditis. A histopathological definition and classification. American Journal of Cardiovascular Pathology, 1, 3-14.
3. Baughman, K.L. (2006). Diagnosis of myocarditis: death of Dallas criteria. Circulation, 113, 593-595. (Pubitemid 43754361)
4. Belloni, E., De Cobelli, F., Esposito, A., e.a. (2007). Myocarditis associated with clozapine studied by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 9, 591-593.
5. Brown, C.A., & O'Connell, J.B. (1995). Myocarditis and idiopathic dilated cardiomyopathy. The American Journal of Medicine, 99, 309-314.
6. Coulter, D., Bate, A., Meyboom, R.A., e.a. (2001). Antipsychotic drugs and heart muscle disorder in inrernational pharmacovigilance: data mining study. BMJ, 322, 1207-1209.
7. Degner, D., Bleich, S., Grohmann, R., e.a. (2000). Myocarditis associated with clozapine. Australian and New Zealand Journal of Psychiatry, 34, 880.
8. Devarajan, S., Kutcher, S., & Dursun, S.M. (2000). Clozapine and sudden death. Lancet, 355, 841.
9. Haas, S.J., Hill, R., Krum, H., e.a. (2007). Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Drug Safety, 30, 47-57.
10. Hägg, S.J., Spigset, S., Bate, A., e.a. (2001). Myocarditis related to clozapine treatment. Journal of clinical psychopharnuicology, 21, 382-388.
11. Hauck, A.J., Kearney, D.L., & Edwards, W.D. (1989). Evaluation of post-mortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clinic Proceedings, 64, 1235-1245.
12. Kane, J., Honigfeld, G., Singer, J., e.a. (1988). Clozapine for the treatment-resistant schizophrenic a double blind comparison versus chlorpromazine. Archives of General Psychiatry, 45, 789-796.
13. Khokhar, W., Rele, K., Birkett, P. (2007). Clozapine related cardiomyopathy. Journal of psychiarric intensive care, 3, 55-57.
14. Kilian, J.G., Kerr, K., Lawrence, G., e.a. (1999). Myocarditis and cardiomyopathy associated with clozapine. Lancet, 354, 1841-1845.
15. Knijff, D.W. W. de, Schepers, P.H.M.W., Blanken-Meijs, J.T.H.M. (2001). Cardiomyopathie tijdens dozapinegebruik. Nederlands Tijdschrift voor Geneeskunde, 145, 1697-1699.
16. La Grenade, L., Graham, D., & Trontell, A. (2001). Myocarditis and cardiomyopathy associated with clozapine use in the United States. New England Journal of Medicine, 345, 224-225.
17. Laser, J.A., Fowles, R.E., & Mason, J.W. (1985). Endomyocardial biopsy. Cardiovascular Clinics, 15, 141-163.
18. Meltzer, H.Y., Lee, M., & Cola, P. (1998). The evolution of treatment resistance: biologic implications. Journal of Clinical Psychopharmacology, 18 (Suppl. 1), 5S-11S. (Pubitemid 28191580)
19. Mendelowitz, A.J., Gerson, S.L., Alvir, J.M.J., e.a. (1995). Clozapine-induced agranulocytosis. Risk factors, monitoring and management. CNS Drugs, 4, 412-421.
20. Merrill, D.B., Dec, G.W., & Goff, D.C. (2005). Adverse cardiac effects associated with clozapine. Journal of Clinical Psychopharmacology, 25, 32-41.
21. Pastor, C.A., & Mehta, M. (2008). Masked clozapine-induced cardiomyopathy. Journal of the American Board of Family Medicine, 21, 70-74.
22. Pieroni, M., Cavallaro, R., Chimenti, G., e.a. (2004). Clozapine-induced hypersensitivity myocarditis. Chest, 126, 1703-1705.
23. Reid, P., McAr thur, M., & Pridmore, S. (2001). Clozapine rechallenge after myocarditis. Australian and New Zealand Journal of Psychiatry, 35, 249.
24. Reinders, J., Parsonage, W., Lange, D., e.a. (2004). Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Australian and New Zealand Journal of Psychiatry, 38, 915-922.
25. Roh, S., Ahn, D., Nam, J.H., e.a. (2006). Cardiomyopathy associated with clozapine. Experimental and Clinical Psychopharmacology, 14, 94-98.
26. Stephens, P. (1990). A review of clozapine: an antipsychotic for treatment-resistant schizophrenia. Comprehensive Psychiatry, 31, 315-326. (Pubitemid 20333845)
27. Tanner, M.A., & Culling, W. (2003). Clozapine assodated dilated cardiomyopathy. Postgraduate Medical Journal, 79, 412-413.
28. Wahlbeck, K., Cheine, K. & Essali, M.A. (1999). Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database of Systematic Reviews, 1, CD000059.
29. Wardenier, M., Slooff, C.J., Arends, J., e.a. (2000). Risperidone, olanzapine and Clozapine in treatment resistant schizophrenia. Acta Neuropsychiatrica, 12, 183-192.
30. Wehmeier, P., Heiser, P., & Remschmidt, H. (2005). Myocarditis, pericarditis ans cardiomyopathy in patients treated with clozapine. Journal of Clinical Pharmacy and Therapeutics, 30, 91-96.
31. Wehmeier, P., Schüler-Springorum, M., Heiser, P., e.a. (2004). Chart review for potential features of myocarditis, pericarditis and cardiomyopathy in children and adolescents treated with clozapine. Journal of Child and Adolescent psychopharmacology, 14, 267-271.